Bromocriptine for Control of Hyperthermia in a Patient with Mixed Autonomic Hyperactivity after Neurosurgery: A Case Report
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kang, Seong Hee | - |
dc.contributor.author | Kim, Min Ja | - |
dc.contributor.author | Shin, Il Young | - |
dc.contributor.author | Park, Dae Won | - |
dc.contributor.author | Sohn, Jang Wook | - |
dc.contributor.author | Yoon, Young Kyung | - |
dc.date.accessioned | 2021-09-06T17:28:46Z | - |
dc.date.available | 2021-09-06T17:28:46Z | - |
dc.date.created | 2021-06-18 | - |
dc.date.issued | 2012-08 | - |
dc.identifier.issn | 1011-8934 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/107887 | - |
dc.description.abstract | Mixed autonomic hyperactivity disorder (MAHD) among patients with acquired brain injury can be rare. A delayed diagnosis of MAHD might exacerbate the clinical outcome and increase healthcare expenses with unnecessary testing. However, MAHD is still an under-recognized and evolving disease entity. A 25-yr-old woman was admitted the clinic due to craniopharyngioma. After an extensive tumor resection, she complained of sustained fever, papillary contraction, hiccup, lacrimation, and sighing. An extensive evaluation of the sustained fever was conducted. Finally, the cause for MAHD was suspected, and the patient was successfully treated with bromocriptine for a month. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | KOREAN ACAD MEDICAL SCIENCES | - |
dc.subject | TRAUMATIC BRAIN-INJURY | - |
dc.subject | INTENSIVE-CARE-UNIT | - |
dc.subject | PAROXYSMAL SYMPATHETIC HYPERACTIVITY | - |
dc.subject | DIENCEPHALIC EPILEPSY | - |
dc.subject | DYSFUNCTION | - |
dc.subject | SEIZURES | - |
dc.subject | FEVER | - |
dc.title | Bromocriptine for Control of Hyperthermia in a Patient with Mixed Autonomic Hyperactivity after Neurosurgery: A Case Report | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Min Ja | - |
dc.contributor.affiliatedAuthor | Park, Dae Won | - |
dc.contributor.affiliatedAuthor | Sohn, Jang Wook | - |
dc.contributor.affiliatedAuthor | Yoon, Young Kyung | - |
dc.identifier.doi | 10.3346/jkms.2012.27.8.965 | - |
dc.identifier.scopusid | 2-s2.0-84866494127 | - |
dc.identifier.wosid | 000307218200021 | - |
dc.identifier.bibliographicCitation | JOURNAL OF KOREAN MEDICAL SCIENCE, v.27, no.8, pp.965 - 968 | - |
dc.relation.isPartOf | JOURNAL OF KOREAN MEDICAL SCIENCE | - |
dc.citation.title | JOURNAL OF KOREAN MEDICAL SCIENCE | - |
dc.citation.volume | 27 | - |
dc.citation.number | 8 | - |
dc.citation.startPage | 965 | - |
dc.citation.endPage | 968 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART001684856 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | General & Internal Medicine | - |
dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
dc.subject.keywordPlus | TRAUMATIC BRAIN-INJURY | - |
dc.subject.keywordPlus | INTENSIVE-CARE-UNIT | - |
dc.subject.keywordPlus | PAROXYSMAL SYMPATHETIC HYPERACTIVITY | - |
dc.subject.keywordPlus | DIENCEPHALIC EPILEPSY | - |
dc.subject.keywordPlus | DYSFUNCTION | - |
dc.subject.keywordPlus | SEIZURES | - |
dc.subject.keywordPlus | FEVER | - |
dc.subject.keywordAuthor | Central Fever | - |
dc.subject.keywordAuthor | Bromocriptine | - |
dc.subject.keywordAuthor | Suprasellar Tumor | - |
dc.subject.keywordAuthor | Neurosurgery | - |
dc.subject.keywordAuthor | Autonomic Dysfunction | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.